• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Vaccines / HPV / Cervarix / Pharmaceutical Companies, Vaccine Mandates and Fiscal Responsibility

Pharmaceutical Companies, Vaccine Mandates and Fiscal Responsibility

February 1, 2011 By Jonathan Leave a Comment

By Norma Erickson, President of SaneVax Inc.

Currently, pharmaceutical companies are lobbying the New York State Legislature to mandate the two most expensive vaccines on the market. HPV vaccine for all sixth graders, and Menactra (meningitis vaccine) for all seventh graders in the state.

Let’s take a look at the cost to taxpayers should these mandates pass. First, let’s consider the proposed Menactra mandate.

According to New York Public School Statistics, there are 202,922 students in the 7th grade throughout the State of New York. Meningitis vaccine costs approximately $150.00 per dose to administer, considering the cost of the vaccine, administration costs, syringes, salaries, keeping school records, distributing parent information, etc…. No one knows how much of this cost will be subsidized by state and/or federal government. It doesn’t really matter, either way – the citizens pay.

At this rate, should the meningitis vaccine mandate pass, it will cost the taxpayers of New York, parents, and insurance companies over $30 million per year. Whoever ends up paying the bill, that 30 million dollars will be added to pharmaceutical company coffers.

Is Meningitis Vaccine Needed?

New York State has a population of approximately 20 million people. Of the 61 reported cases of meningitis, 46% occurred  in congested, underprivileged areas with unsanitary environments. There are no less than seven different types of bacterial meningitis each caused by a different strain of bacteria. The vaccine only covers one variety. There are no records indicating whether any of the 61 reported cases occurred in vaccinated individuals. Even the vaccine manufacturer says their product is not effective for all individuals. Furthermore, meningitis is curable with antibiotics, providing it is diagnosed properly.

The package insert for Menactra clearly indicates that it is not guaranteed to protect everyone and can cause Guillane-Barre and Palsy.

Meningitis is primarily a Sub-Sahara, Africa disease problem. Every country and/or state should consider the potential risk of any disease based on the incident rate in their own populace, not worldwide statistics.

The SaneVax Team believes the risk to benefit and the cost to benefit ratios do not justify the expense of mandating this vaccine in the State of New York. We believe the taxpayers of the state would agree that the $30 million would much better spent on things like sanitation or economic development.

Keep in mind, this analysis does not include the proposed mandate for HPV vaccines. Should human papillomavirus vaccines also be mandated, the citizens of New York would be contributing an additional $68 million (estimate based on $350/series of shots) to pharmaceutical companies’ bottom line.

Almost a billion dollars, straight from the citizens to pharmaceutical companies–think about it! Do the taxpayers in the State of New York want to support the pharmaceutical industry, or spend their limited funds on programs that directly benefit their population?

Read More….

Related

Filed Under: Cervarix, Cervical Cancer, Gardasil / Silgard, Menactra, Pharmaceuticals, Vaccine Adverse Events, Vaccine Politics/People Tagged With: Anal Cancer, Autoimmune Diseases, cervarix, Cervical Cancer HPV, Gardasil/Silgard, GlaxoSmithKline, HPV, HPV VACCINES, menactra, Merck, pharmaceuticals, Sane Vax, STD's, Vaccine Adverse Reactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Cervarix: New medical conditions for both my daughters

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

Guard Yourself: Gardasil Documentary Short

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2023 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in

 

Loading Comments...